120
Views
2
CrossRef citations to date
0
Altmetric
Menopause

Effects of menopause on hepatic 11β-hydroxysteroid dehydrogenase type 1 activity and adrenal sensitivity to adrenocorticotropin in healthy non-obese women

, , , , , & show all
Pages 794-799 | Received 09 May 2010, Accepted 05 Jul 2010, Published online: 08 Jul 2011

References

  • ShenW, PunyanityaM, SilvaAM, ChenJ, GallagherD, SardinhaLB, AllisonDB, HeymsfieldSB. Sexual dimorphism of adipose tissue distribution across the lifespan: a cross-sectional whole-body magnetic resonance imaging study. Nutr Metab (Lond) 2009;6:17.
  • CarrMC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404–2411.
  • MendelsohnME, KarasRH. Molecular and cellular basis of cardiovascular gender differences. Science 2005;308:1583–1587.
  • WalkerBR, AndrewR. Tissue production of cortisol by 11β-hydroxysteroid dehydrogenase type 1 and metabolic disease. Ann NY Acad Sci 2006;1083:165–184.
  • RoelfsemaF, van den BergG, FrölichM, VeldhuisJD, van EijkA, BuurmanMM, EtmanBH. Sex-dependent alteration in cortisol response to endogenous adrenocorticotropin. J Clin Endocrinol Metab 1993;77:234–240.
  • KitayJI. Pituitary–adrenal function in the rat after gonadectomy and gonadal hormone replacement. Endocrinology 1963;73:253–260.
  • GenazzaniAR, Lemarchand-BéraudT, AubertML, FelberJP. Pattern of plasma ACTH, hGH, and cortisol during menstrual cycle. J Clin Endocrinol Metab 1975;41:431–437.
  • AtanasovAG, NashevLG, SchweizerRA, FrickC, OdermattA. Hexose-6-phosphate dehydrogenase determines the reaction direction of 11β-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Lett 2004;571:129–133.
  • LaveryGG, WalkerEA, DraperN, JeyasuriaP, MarcosJ, ShackletonCH, ParkerKL, WhitePC, StewartPM. Hexose-6-phosphate dehydrogenase knock-out mice lack 11 β-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J Biol Chem 2006;281:6546–6551.
  • AtanasovAG, OdermattA. Readjusting the glucocorticoid balance: an opportunity for modulators of 11β-hydroxysteroid dehydrogenase type 1 activity? Endocr Metab Immune Disord Drug Targets 2007;7:125–140.
  • WhitePC, MuneT, AgarwalAK. 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 1997;18:135–156.
  • MortonNM, PatersonJM, MasuzakiH, HolmesMC, StaelsB, FievetC, WalkerBR, FlierJS, MullinsJJ, SecklJR. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 2004;53:931–938.
  • MasuzakiH, PatersonJ, ShinyamaH, MortonNM, MullinsJJ, SecklJR, FlierJS. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166–2170.
  • MasuzakiH, YamamotoH, KenyonCJ, ElmquistJK, MortonNM, PatersonJM, ShinyamaH, SharpMG, FlemingS, MullinsJJ, et al. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 2003;112:83–90.
  • PatersonJM, MortonNM, FievetC, KenyonCJ, HolmesMC, StaelsB, SecklJR, MullinsJJ. Metabolic syndrome without obesity: hepatic overexpression of 11β-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci USA 2004;101:7088–7093.
  • AnderssonT, SöderströmI, SimonytéK, OlssonT. Estrogen reduces 11β-hydroxysteroid dehydrogenase type 1 in liver and visceral, but not subcutaneous, adipose tissue in rats. Obesity (Silver Spring) 2010;18:470–475.
  • PaulsenSK, NielsenMP, RichelsenB, BruunJM, FlyvbjergA, PedersenSB. Upregulation of adipose 11β-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen. Obesity (Silver Spring) 2008;16:731–735.
  • HammamiMM, SiiteriPK. Regulation of 11β-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. J Clin Endocrinol Metab 1991;73:326–334.
  • WhorwoodCB, SheppardMC, StewartPM. Tissue specific effects of thyroid hormone on 11β-hydroxysteroid dehydrogenase gene expression. J Steroid Biochem Mol Biol 1993;46:539–547.
  • LowSC, ChapmanKE, EdwardsCR, WellsT, RobinsonIC, SecklJR. Sexual dimorphism of hepatic 11β-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns. J Endocrinol 1994;143:541–548.
  • EscherG, GalliI, VishwanathBS, FreyBM, FreyFJ. Tumor necrosis factor α and interleukin 1β enhance the cortisone/cortisol shuttle. J Exp Med 1997;186:189–198.
  • LowSC, AssaadSN, RajanV, ChapmanKE, EdwardsCR, SecklJR. Regulation of 11β-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney. J Endocrinol 1993;139:27–35.
  • DieudonnéMN, SammariA, Dos SantosE, LeneveuMC, GiudicelliY, PecqueryR. Sex steroids and leptin regulate 11β-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: sex specificities. J Steroid Biochem Mol Biol 2006;99:189–196.
  • JamiesonA, WallaceAM, AndrewR, NunezBS, WalkerBR, FraserR, WhitePC, ConnellJM. Apparent cortisone reductase deficiency: a functional defect in 11β-hydroxysteroid dehydrogenase type 1. J Clin Endocrinol Metab 1999;84:3570–3574.
  • GuS, RippSL, ProughRA, GeogheganTE. Dehydroepiandrosterone affects the expression of multiple genes in rat liver including 11β-hydroxysteroid dehydrogenase type 1: a cDNA array analysis. Mol Pharmacol 2003;63:722–731.
  • ApostolovaG, SchweizerRA, BalazsZ, KostadinovaRM, OdermattA. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue. Am J Physiol Endocrinol Metab 2005;288:957–964.
  • BalazsZ, SchweizerRA, FreyFJ, Rohner-JeanrenaudF, OdermattA. DHEA induces 11 -HSD2 by acting on CCAAT/enhancer-binding proteins. J Am Soc Nephrol 2008;19:92–101.
  • KimSB, ChalbotS, PomponD, JoDH, MorfinR. The human cytochrome P4507B1: catalytic activity studies. J Steroid Biochem Mol Biol 2004;92:383–389.
  • HennebertO, ChalbotS, AlranS, MorfinR. Dehydroepiandrosterone 7α-hydroxylation in human tissues: possible interference with type 1 11β-hydroxysteroid dehydrogenase-mediated processes. J Steroid Biochem Mol Biol 2007;104:326–333.
  • MooreJS, MonsonJP, KaltsasG, PutignanoP, WoodPJ, SheppardMC, BesserGM, TaylorNF, StewartPM. Modulation of 11β-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. J Clin Endocrinol Metab 1999;84:4172–4177.
  • SunK, YangK, ChallisJR. Differential expression of 11β-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes. J Clin Endocrinol Metab 1997;82:300–305.
  • KudielkaBM, Schmidt-ReinwaldAK, HellhammerDH, KirschbaumC. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment. Neuroendocrinology 1999;70:422–430.
  • De LeoV, la MarcaA, TalluriB, D'AntonaD, MorganteG. Hypothalamo–pituitary–adrenal axis and adrenal function before and after ovariectomy in premenopausal women. Eur J Endocrinol 1998;138:430–435.
  • GenazzaniAR, PluchinoN, BegliuominiS, StomatiM, BernardiF, PieriM, CasarosaE, PalumboM, GenazzaniAD, LuisiM. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women. Gynecol Endocrinol 2006;22:627–635.
  • LiuCH, LaughlinGA, FischerUG, YenSS. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: evidence for a reduced 17,20-desmolase enzymatic activity. J Clin Endocrinol Metab 1990;71:900–906.
  • StomatiM, MonteleoneP, CasarosaE, QuiriciB, PuccettiS, BernardiF, GenazzaniAD, RovatiL, LuisiM, GenazzaniAR. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause. Gynecol Endocrinol 2000;14:342–363.
  • ZallocchiM. Adrenal 11β-hydroxysteroid dehydrogenase activity in response to stress. Can J Physiol Pharmacol 2004;82:422–425.
  • Zuckerman-LevinN, TiosanoD, EisenhoferG, BornsteinS, HochbergZ. The importance of adrenocortical glucocorticoids for adrenomedullary and physiological response to stress: a study in isolated glucocorticoid deficiency. J Clin Endocrinol Metab 2001;86:5920–5924.
  • ColeTJ, BlendyJA, MonaghanAP, KrieglsteinK, SchmidW, AguzziA, FantuzziG, HummlerE, UnsickerK, SchützG. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995;9:1608–1621.
  • CohenPG. Estradiol induced inhibition of 11β-hydroxysteroid dehydrogenase 1: an explanation for the postmenopausal hormone replacement therapy effects. Med Hypotheses 2005;64:989–991.
  • Ligeiro de OliveiraAP, Oliveira-FilhoRM, da SilvaZL, BorelliP, Tavares de LimaW. Regulation of allergic lung inflammation in rats: interaction between estradiol and corticosterone. Neuroimmunomodulation 2004;11:20–27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.